Literature DB >> 11705747

Hepatic and extrahepatic factors critical for liver injury during lipopolysaccharide exposure.

F Moulin1, B L Copple, P E Ganey, R A Roth.   

Abstract

Bacterial endotoxin [lipopolysaccharide (LPS)] causes liver injury in vivo that is dependent on platelets, neutrophils [polymorphonuclear leukocytes (PMNs)], and several inflammatory mediators, including thrombin. We tested the hypothesis that thrombin contributes to LPS-induced hepatocellular injury through direct interactions with platelets and/or PMNs in vitro. Perfusion of isolated livers from LPS-treated rats with buffer containing thrombin resulted in a significant increase in alanine aminotransferase (ALT) activity in the perfusion medium, indicating hepatocellular damage. This effect was completely abolished by prior depletion of PMNs from the LPS-treated donor rats but not by depletion of platelets, suggesting interaction between thrombin and PMNs in the pathogenesis. Thrombin did not, however, enhance degranulation of rat PMNs in vitro, and it was not directly toxic to isolated rat hepatocytes in the presence of PMNs even after LPS exposure, suggesting that hepatocellular killing by the PMN-thrombin combination requires the intervention of an additional factor(s) within the liver. In livers from naive donors perfused with buffer containing PMNs and LPS, no injury occurred in the absence of thrombin. Addition of thrombin (10 nM) to the medium caused pronounced ALT release. These results indicate that thrombin and PMNs are sufficient extrahepatic requirements for LPS-induced hepatocellular damage in intact liver.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11705747     DOI: 10.1152/ajpgi.2001.281.6.G1423

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  7 in total

1.  Phagocytic and oxidative burst activity of neutrophils in the end stage of liver cirrhosis.

Authors:  Anatol Panasiuk; Jolanta Wysocka; Elzbieta Maciorkowska; Bozena Panasiuk; Danuta Prokopowicz; Janusz Zak; Karol Radomski
Journal:  World J Gastroenterol       Date:  2005-12-28       Impact factor: 5.742

2.  Tissue-engineered model for real-time monitoring of liver inflammation.

Authors:  Rohit Jindal; Suraj J Patel; Martin L Yarmush
Journal:  Tissue Eng Part C Methods       Date:  2010-09-28       Impact factor: 3.056

3.  Downregulation effects of beta-elemene on the levels of plasma endotoxin, serum TNF-alpha, and hepatic CD14 expression in rats with liver fibrosis.

Authors:  Jianguo Liu; Zhe Zhang; Jiechang Gao; Jiwen Xie; Lin Yang; Shenjun Hu
Journal:  Front Med       Date:  2011-03-17       Impact factor: 4.592

4.  Concurrent Inflammation Augments Antimalarial Drugs-Induced Liver Injury in Rats.

Authors:  Hossein Niknahad; Reza Heidari; Roya Firuzi; Farzaneh Abazari; Maral Ramezani; Negar Azarpira; Massood Hosseinzadeh; Asma Najibi; Arastoo Saeedi
Journal:  Adv Pharm Bull       Date:  2016-12-22

5.  FR167653 attenuates murine immunological liver injury.

Authors:  Hong-Wei Yao; Jun Li; Ji-Qiang Chen
Journal:  World J Gastroenterol       Date:  2004-08-01       Impact factor: 5.742

6.  Effect of polymyxin B-immobilized fiber hemoperfusion on respiratory impairment, hepatocellular dysfunction, and leucopenia in a neonatal sepsis model.

Authors:  Mohamed Hamed Hussein; Ghada A Daoud; Hiroki Kakita; Shin Kato; Tatenobu Goto; Michi Kamei; Kenji Goto; Yasuhiko Ozaki; Tetsuya Ito; Sumio Fukuda; Ineko Kato; Satoshi Suzuki; Takashi Hashimoto; Hajime Togari
Journal:  Pediatr Surg Int       Date:  2009-10-03       Impact factor: 1.827

Review 7.  Inflammatory stress and idiosyncratic hepatotoxicity: hints from animal models.

Authors:  Xiaomin Deng; James P Luyendyk; Patricia E Ganey; Robert A Roth
Journal:  Pharmacol Rev       Date:  2009-09       Impact factor: 25.468

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.